Lundbeck CDM delivers end-to-end API and drug product solutions from development to commercial scale.

Reset all filters
01 6Azilect
Main Therapeutic Indication : Neuroscience and Mental Health
Currency : USD
2015 Revenue in Millions : 225
2014 Revenue in Millions : 219
Growth (%) : -3%
Main Therapeutic Indication : Neuroscience/Mental Health
Currency : USD
2014 Revenue in Millions : 8%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Neuroscience/Mental Health
Currency : USD
2014 Revenue in Millions : 15.40%
2013 Revenue in Millions :
Growth (%) :

Main Therapeutic Indication : Neuroscience and Mental Health
Currency : USD
2015 Revenue in Millions : 428
2014 Revenue in Millions : 384
Growth (%) : -10%

Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2016 Revenue in Millions : 410
2015 Revenue in Millions : 384
Growth (%) : 7

Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 170
2016 Revenue in Millions : 410
Growth (%) : -59




